Screener
Celldex Therapeutics CLDX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's book value per share?
- Celldex Therapeutics (CLDX) reported book value per share of $9.18 in Q2 2026.
- How has Celldex Therapeutics's book value per share changed year-over-year?
- Celldex Therapeutics's book value per share decreased by 7.0% year-over-year, from $9.87 to $9.18.
- What is the long-term trend for Celldex Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Celldex Therapeutics's book value per share has grown at a 2.4% compound annual growth rate (CAGR), from $7.06 to $7.94.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Celldex Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude